Search

Author/Creator Karkada, Naveen

1. A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years. Issue 7 (3rd August 2019)

Authors:
Schwarz, Tino F.; Huang, Li-Min; Valencia, Alejandra; Panzer, Falko; Chiu, Cheng-Hsun; Decreux, Annabelle; Poncelet, Sylviane; Karkada, Naveen; Folschweiller, Nicolas; Lin, Lan; Dubin, Gary; Struyf, Frank
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 15:Issue 7/8(2019)
Page Start:
1970
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study. (5th September 2020)

Authors:
Tota, Joseph E; Struyf, Frank; Hildesheim, Allan; Gonzalez, Paula; Ryser, Martin; Herrero, Rolando; Schussler, John; Karkada, Naveen; Rodriguez, Ana Cecilia; Folschweiller, Nicolas; Porras, Carolina; Schiffman, Mark; Schiller, John T; Quint, Wim; Kreimer, Aimée R; Lehtinen, Matti; Wheeler, Cosett...
Journal:
Journal of infectious diseases
Issue:
Volume 223:Number 9(2021)
Page Start:
1576
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy of the AS04-adjuvanted HPV-16/18 vaccine in young Chinese women with oncogenic HPV infection at baseline: post-hoc analysis of a randomized controlled trial. Issue 4 (3rd April 2021)

Authors:
Hu, Shangying; Xu, Xiaoqian; Zhu, Fengcai; Hong, Ying; Hu, Yuemei; Zhang, Xun; Pan, Qinjing; Zhang, Wenhua; Zhang, Chengfu; Yang, Xiaoping; Yu, Jiaxi; Zhu, Jiahong; Zhu, Yejiang; Chen, Feng; Zhao, Shuang; Karkada, Naveen; Tang, Haiwen; Bi, Dan; Struyf, Frank; Zhao, Fanghui
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 17:Issue 4(2021)
Page Start:
955
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials. (7th November 2019)

Authors:
Tota, Joseph E; Struyf, Frank; Sampson, Joshua N; Gonzalez, Paula; Ryser, Martin; Herrero, Rolando; Schussler, John; Karkada, Naveen; Rodriguez, Ana Cecilia; Folschweiller, Nicolas; Porras, Carolina; Schiffman, Mark; Schiller, John T; Quint, Wim; Kreimer, Aimée R; Wheeler, Cosette M; Hildesheim, ...
Journal:
Journal of the National Cancer Institute
Issue:
Volume 112:Number 8(2020)
Page Start:
818
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trial. (15th July 2019)

Authors:
Zhu, Feng‐Cai; Hu, Shang‐Ying; Hong, Ying; Hu, Yue‐Mei; Zhang, Xun; Zhang, Yi‐Ju; Pan, Qin‐Jing; Zhang, Wen‐Hua; Zhao, Fang‐Hui; Zhang, Cheng‐Fu; Yang, Xiaoping; Yu, Jia‐Xi; Zhu, Jiahong; Zhu, Yejiang; Chen, Feng; Zhang, Qian; Wang, Hong; Wang, Changrong; Bi, Jun; Xue, Shiyin
Journal:
Cancer medicine
Issue:
Volume 8:Number 14(2019:Oct.)
Page Start:
6195
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy, immunogenicity, and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in Chinese women aged 18–25 years: event‐triggered analysis of a randomized controlled trial. (20th December 2016)

Authors:
Zhu, Feng‐cai; Hu, Shang‐Ying; Hong, Ying; Hu, Yue‐Mei; Zhang, Xun; Zhang, Yi‐Ju; Pan, Qin‐Jing; Zhang, Wen‐Hua; Zhao, Fang‐Hui; Zhang, Cheng‐Fu; Yang, Xiaoping; Yu, Jia‐Xi; Zhu, Jiahong; Zhu, Yejiang; Chen, Feng; Zhang, Qian; Wang, Hong; Wang, Changrong; Bi, Jun; Xue, Shiyin
Journal:
Cancer medicine
Issue:
Volume 6:Number 1(2017:Jan.)
Page Start:
12
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study. Issue 10 (October 2016)

Authors:
Wheeler, Cosette M; Skinner, S Rachel; Del Rosario-Raymundo, M Rowena; Garland, Suzanne M; Chatterjee, Archana; Lazcano-Ponce, Eduardo; Salmerón, Jorge; McNeil, Shelly; Stapleton, Jack T; Bouchard, Céline; Martens, Mark G; Money, Deborah M; Quek, Swee Chong; Romanowski, Barbara; Vallejos, Carlos ...
Journal:
Lancet infectious diseases
Issue:
Volume 16:Issue 10(2016:Oct.)
Page Start:
1154
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study. Issue 10 (October 2016)

Authors:
Wheeler, Cosette M; Skinner, S Rachel; Del Rosario-Raymundo, M Rowena; Garland, Suzanne M; Chatterjee, Archana; Lazcano-Ponce, Eduardo; Salmerón, Jorge; McNeil, Shelly; Stapleton, Jack T; Bouchard, Céline; Martens, Mark G; Money, Deborah M; Quek, Swee Chong; Romanowski, Barbara; Vallejos, Carlos ...
Journal:
Lancet infectious diseases
Issue:
Volume 16:Issue 10(2016:Oct.)
Page Start:
1154
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants. Issue 3 (3rd March 2016)

Authors:
Li, Rong-cheng; Huang, Teng; Li, Yanping; Wang, Lao-Hong; Tao, Junhui; Fu, Botao; Si, Guoai; Nong, Yi; Mo, Zhaojun; Liao, XueYan; Luan, Ivy; Tang, Haiwen; Rathi, Niraj; Karkada, Naveen; Han, Htay Htay
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 12:Issue 3(2016)
Page Start:
785
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants. Issue 1 (2nd January 2017)

Authors:
Lalwani, Sanjay K.; Agarkhedkar, Sharad; Sundaram, Balasubramanian; Mahantashetti, Niranjana S.; Malshe, Nandini; Agarkhedkar, Shalaka; Van Der Meeren, Olivier; Mehta, Shailesh; Karkada, Naveen; Han, Htay Htay; Mesaros, Narcisa
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 13:Issue 1(2017)
Page Start:
120
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗